Does GOLIMUMAB Cause Upper respiratory tract infection? 579 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 579 reports of Upper respiratory tract infection have been filed in association with GOLIMUMAB (SIMPONI ARIA). This represents 0.8% of all adverse event reports for GOLIMUMAB.
579
Reports of Upper respiratory tract infection with GOLIMUMAB
0.8%
of all GOLIMUMAB reports
262
Deaths
239
Hospitalizations
How Dangerous Is Upper respiratory tract infection From GOLIMUMAB?
Of the 579 reports, 262 (45.3%) resulted in death, 239 (41.3%) required hospitalization, and 157 (27.1%) were considered life-threatening.
Is Upper respiratory tract infection Listed in the Official Label?
Yes, Upper respiratory tract infection is listed as a known adverse reaction in the official FDA drug label for GOLIMUMAB.
What Other Side Effects Does GOLIMUMAB Cause?
Drug ineffective (17,959)
Rheumatoid arthritis (12,272)
Pain (11,443)
Fatigue (9,626)
Off label use (8,764)
Alopecia (8,394)
Rash (8,331)
Joint swelling (8,264)
Arthralgia (7,968)
Abdominal discomfort (7,902)
What Other Drugs Cause Upper respiratory tract infection?
ADALIMUMAB (3,306)
ETANERCEPT (2,948)
TOFACITINIB (1,805)
RITUXIMAB (1,713)
ABATACEPT (1,623)
METHOTREXATE (1,576)
TOCILIZUMAB (1,455)
APREMILAST (1,437)
PREDNISONE (1,354)
SECUKINUMAB (1,339)
Which GOLIMUMAB Alternatives Have Lower Upper respiratory tract infection Risk?
GOLIMUMAB vs GOLODIRSEN
GOLIMUMAB vs GONADORELIN
GOLIMUMAB vs GONADOTROPHIN, CHORIONIC
GOLIMUMAB vs GOSERELIN
GOLIMUMAB vs GRAMICIDIN